Copyright
©The Author(s) 2023.
World J Clin Pediatr. Dec 9, 2023; 12(5): 295-309
Published online Dec 9, 2023. doi: 10.5409/wjcp.v12.i5.295
Published online Dec 9, 2023. doi: 10.5409/wjcp.v12.i5.295
Type of RTA | Type 1 RTA | Type 2 RTA | Type 3 RTA | Type 4 RTA | |
Prevalence | The most common type of RTA (1-2/100.000) | Less common than type 1 RTA (0.5/100.000) | Very rare | Slightly less common than type 1 RTA (1/100.000) | |
Location of defect | Distal nephron | Proximal nephron | Variable | Collecting duct | |
Etiology | Primary | Sporadic or hereditary (mutation of SLC4A1, H+-K+-ATPase, H+-ATPase) | Sporadic or hereditary (mutation of CA-IV, NHE-3, NBC-1) | Mutation in CA-II | PHA-1, PHA-2 (Gordon’s syndrome) |
Secondary | Autoimmune: Sjogren’s, SLE, RA, PBC; Nephrotoxins: Amphotercicn B, trimethoprim, lithium; Miscellaneous: Sarcoidosis, amyloidosis, obstructive uropathy | Autoimmune: Sjogren’s; Nephrotoxins: Tetracycline, topiramate, valproate, acetazolamide; Metabolic: Wilson’s disease, cystinosis, Lowe’s syndrome, galactosemia, chronic hypocalcemia; Hereditary fructose intolerance, tyrosinemia; Miscellaneous: Multiple myeloma, amyloidosis | Type 1 RTA with secondary proximal tubule dysfunction, type 2 RTA with secondary distal tubule dysfunction | Aldosterone deficiency or aldosterone resistance: Hypoaldosteronism, ACEIs, ARBs; Hyporeninemic hypoaldosteronism: Diabetes, sickle cell disease; Tubulointerstitial disease (eGFR: 20-50 ml/min); Drugs: Potassium sparing diuretics, NSAIDs, trimethoprim, pentamidine, cyclosporine, tacrolimus | |
Pathogenesis | Impaired hydrogen ion secretion & reduced bicarbonate reabsorption in the distal tubules | Impaired bicarbonate reabsorption in the proximal tubules | Impaired distal acidification and reduced bicarbonate reabsorption | Impaired hydrogen ion secretion and decreased potassium excretion due to reduced aldosterone activity | |
Degree of acidosis | Severe | Mild to moderate | Mild | Mild to moderate | |
Key features | Acidemia, hypobicarbonatemia, inability to acidify urine properly, and loss of bicarbonate ions in urine. Hypokalemia is common | Metabolic acidosis, loss of bicarbonate ions in urine, hypobicarbonatemia, electrolyte imbalances (e.g., hypokalemia, hypophosphatemia) | Metabolic acidosis, hypobicarbonatemia, variable features depending on the underlying systemic disease or medication | Metabolic acidosis, hyperkalemia, associated with hypoaldosteronism or resistance to aldosterone, potential electrolyte imbalances (e.g., hyponatremia, mild hyperchloremic acidosis) | |
Risk of renal calcification | High | Lower than type 1 RTA | Very low (variable) | Unknown |
Type of RTA | Urine pH | Fractional bicarbonate excretion |
Type 1 RTA | Does not decrease | Normal or decreased |
Type 2 RTA | Decreases | Increased |
Type 3 RTA | Variable | Variable |
Type 4 RTA | Does not decrease | Decreased |
Feature | Type 1 RTA | Type 2 RTA | |
Prevalence | More common than type 2 RTA | Less common than type 1 RTA | |
Cause | Usually isolated, inherited, autosomal recessive forms are associated with hearing loss | Usually secondary to a systemic disease, most often metabolic disease, e.g., Fanconi syndrome | |
Clinical features | Nephrocalcinosis | Often present | Occasionally present |
Polyuria (increased urine output) | Common | Common | |
Polydipsia (increased thirst) | Common | Common | |
Dehydration | Less common | Less common | |
Bone abnormalities | Usually, severe | Variable | |
Failure to thrive (children) | Occasional | Uncommon | |
Rickets/osteomalacia (children) | Occasional | Uncommon | |
Metabolic acidosis | Severe acidosis; is easily corrected with bicarbonate supplementation | Usually milder but difficult to correct; requires high doses of bicarbonate supplementation | |
Laboratory Finding | Serum HCO3- (bicarbonate) | Decreased | Decreased |
Serum potassium | Low | Normal/low | |
Urine pH | > 5.5 | < 5.5 | |
Fractional excretion of bicarbonate | < 5% | > 15% | |
Urine-blood PCO2 | < 20 mmHg | > 20 mmHg | |
Phosphaturia and hypophosphatemia | Absent | Present (variable) | |
Tubular defects – low-molecular-weight proteinuria, aminoaciduria, glycosuria | Absent | Present (variable) | |
Hypercalciuria | Often present | Occasionally present |
Gene involved | Inheritance | Location of gene | RTA type caused | Affected protein | Main clinical feature |
SLC4A1 gene | AD | 17q21-q22 | Type 1 RTA | AE1 | Type 1 RTA, hereditary spherocytosis |
AR | |||||
CA2 gene | AR | 8q21.2 | Type 1 RTA, type 3 RTA | CA II | Osteopetrosis, brain calcification, RTA |
ATP6V1B1 | AR | 2q13 | Type 1 RTA | H+-ATPase | Sensorineural deafness |
ATP6V0A4 | 7q33-q34 | ||||
SLC4A2 gene | AR | 7q36.1 | Type 2 RTA | AE2 | PBC |
SLC4A4 gene | AR | 4q13.3 | Type 2 RTA | (NBC) | Ocular abnormalities |
SLC2A2 gene | AR | 3q26.2 | Type 2 RTA | GLUT2 | Fanconi-Bickel syndrome, NIDDM |
CLCN5 gene | X-linked recessive | Xp11.23 | Type 2 RTA | H+/Cl- exchanger | Dent disease type 1, HHR |
OCRL1 gene | X-linked recessive | Xq26.1. | Type 2 RTA | OCRL enzyme | Dent disease, type 2, LOCRS |
NR3C2 (MR) gene | AD | 4p | Type 4 RTA | MLR NRC | PHA1, hyperkalemia, salt wasting & hypotension |
SCNN1A, SCNN1B, and SCNN1G genes | AR | SCNN1A (12p3). SCNN1B, & SCNN1G located in (16p12-p13) | Type 4 RTA | ENaC | Liddle syndrome, sodium loss from the kidneys and other organs, including the sweat glands, salivary glands, and colon |
Modality | Advantages | Limitations |
X-ray | Readily available; Cost-effective; Quick initial assessment; Suitable for detecting large, dense stones | Limited sensitivity for smaller or radiolucent stones; No detailed anatomical information |
Ultrasound | Can be used to assess kidney size, shape, and echogenicity; Non-invasive; Real-time imaging; Widely available; Initial assessment of kidney stones and medullary cyst | Reduced sensitivity for smaller or deeply located calcifications; Limited anatomical details |
CT | Excellent spatial resolution; Detailed cross-sectional images; Highly sensitive for detecting kidney stones and calcifications; Assesses impact on kidney function and urinary tract | Involves exposure to ionizing radiation; Contrast agents may be contraindicated in some patients; Not suitable for all patients due to contrast use |
MRI | No ionizing radiation; Detailed images of the extent of calcification and surrounding soft tissue damage; Multiplanar imaging capability; Can provide information on tissue characteristics and perfusion | It may not be as readily available as other modalities; Limited sensitivity for detecting small or faint calcifications |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS, Elbeltagi R, Hasan S, Hamza MB. Renal calcification in children with renal tubular acidosis: What a paediatrician should know. World J Clin Pediatr 2023; 12(5): 295-309
- URL: https://www.wjgnet.com/2219-2808/full/v12/i5/295.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v12.i5.295